Accentuating the caveat emptor perspective with critical commentary on financial disclosure. I adopt a skeptical persona and look for chinks in the teflon coating of financial disclosure. My job is to identify financial warts. Perhaps a Black Swan. Disclosure: I do not hold positions in stocks mentioned for three trading days before or after blog post.
Monday, September 14, 2009
Tenet Lets Cat Out Of The Bag
Tenet Health Care (THC) popped its stock some 8% by announcing investor positive changes to its guidance. Q3 is coming in better than expected. Q3 is usually slow and this time it was not as bad as previously thought. The problem I have is the extent to which Tenet is explaining its changes in guidance. The share is very low and abets volatility. The louder you beat the drum of investor relations that better the stock performs. The quarter is almost over so the sneak peak guidance change challenges the concept of Fair Disclosure.